Z-1295-2018 Class II Terminated

Recalled by Magellan Diagnostics, Inc. — North Billerica, MA

FDA device recall Z-1295-2018 was initiated by Magellan Diagnostics, Inc. on Jan 9, 2018 and is designated Class II. Reason for recall: The incorrect placement of AA batteries into certain LeadCare II Blood Lead Analyzer may cause the batteries to overheat, and the chance that a user could burn their fingers if the batteries are… The recall status is terminated (terminated Dec 11, 2020). Affected quantity: 6,143.

Recall details

Product Type
Devices
Report Date
Apr 11, 2018
Initiation Date
Jan 9, 2018
Termination Date
Dec 11, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,143

Product description

LeadCare II Blood Lead Analyzer Part Numbers: 70-6760, 70-6529-R, 70-6760-P, 70-6760-R. Intended for in vitro (external) use only.

Reason for recall

The incorrect placement of AA batteries into certain LeadCare II Blood Lead Analyzer may cause the batteries to overheat, and the chance that a user could burn their fingers if the batteries are removed while hot.

Distribution pattern

Worldwide Distribution

Code information

Part Numbers: 70-6760, 70-6529-R, 70-6760-P, and 70-6760-R. All LeadCare II and LeadCare Plus Blood Lead Analyzers with battery boards versions B and O.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1295-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1295-2018. Report a data issue: hello@regdatalab.com.